Stephen Ray Mitchell
Director at Vanda Pharmaceuticals Inc. (VNDA)
Stephen Ray Mitchell has filed 14 insider reports with the SEC since June 2021, as director at Vanda Pharmaceuticals Inc. (VNDA). Stephen Ray Mitchell made no open-market purchases or sales in the last 12 months. The latest filing, on June 8, 2026, reports grant or award at Vanda Pharmaceuticals Inc. (VNDA).
- Filings
- 14
- Companies
- 1
- Bought on market
- None
- Sold on market
- $540K
Companies where Stephen Ray Mitchell is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 112,846 | $540K | $3.81 | Jun 8, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 4, 2026VNDADirector Mitchell Stephen Ray was granted 41,600 shares, increasing direct ownership by 58% to 112,846 unitsForm 4Grant or award
- May 18, 2026VNDADirector Mitchell Stephen Ray gifted 25,836 shares, decreasing direct ownership by 27% to 71,246 unitsForm 4Gift
- Jun 13, 2025-$32.1KVNDADirector Mitchell Stephen Ray sold $32,130 worth of shares (7,000 units at $4.59), decreasing direct ownership by 7% to 97,082 unitsForm 4Open-market sale
- Jun 13, 2025~$32.2KVNDAStephen Ray Mitchell plans to sell 7,000 shares (~$32.2K)Form 144Planned sale
- Jun 5, 2025VNDADirector Mitchell Stephen Ray was granted 59,225 shares, increasing direct ownership by 132% to 104,082 unitsForm 4Grant or award
- Nov 14, 2024-$25.9KVNDADirector Mitchell Stephen Ray sold $25,863 worth of shares (5,000 units at $5.17), decreasing direct ownership by 10% to 44,857 unitsForm 4Open-market sale
- May 17, 2024VNDAMitchell Stephen Ray was granted 20,529 shares, increasing direct ownership by 70% to 49,857 unitsForm 4Grant or award
- Aug 10, 2023-$39.3KVNDASEC Form 4: Mitchell Stephen Ray sold $39,349 worth of shares (6,500 units at $6.05), decreasing direct ownership by 18% to 29,328 unitsForm 4Open-market sale
- Jun 8, 2023VNDASEC Form 4 filed by Mitchell Stephen RayForm 4Grant or award
- Jun 16, 2022VNDASEC Form 4: Mitchell Stephen Ray was granted 12,006 shares, increasing direct ownership by 184% to 18,521 unitsForm 4Grant or award
- Jun 13, 2022-$25.6KVNDASEC Form 4: Mitchell Stephen Ray sold $25,593 worth of shares (2,700 units at $9.48), decreasing direct ownership by 29% to 6,515 units (tax liability)Form 4Open-market sale
- Sep 9, 2021-$320KVNDASEC Form 4: Mitchell Stephen Ray sold $319,976 worth of Common Stock (19,109 units at $16.74) and exercised 19,109 units of Common Stock at a strike of $12.03Form 4Exercise or conversion of a derivativeOpen-market sale
- Jun 15, 2021-$97.1KVNDASEC Form 4: Mitchell Stephen Ray exercised 4,015 units of Common Stock at a strike of $10.57 and sold $97,122 worth of Common Stock (5,000 units at $19.42), decreasing direct ownership by 10% to 9,215 units to cover withholding taxForm 4Exercise or conversion of a derivativeOpen-market sale
- Jun 10, 2021VNDASEC Form 4: Mitchell Stephen Ray was granted 5,000 units of Common Stock, increasing direct ownership by 96% to 10,200 unitsForm 4Grant or award
Compare Stephen Ray Mitchell with
- Stephen Ray Mitchell vs Charles Cliff Duncan1 shared
- Stephen Ray Mitchell vs Daniel Patrick McGuire1 shared
- Stephen Ray Mitchell vs Phaedra Chrousos1 shared
- Stephen Ray Mitchell vs Richard W Dugan1 shared
- Stephen Ray Mitchell vs Anne Sempowski Ward1 shared
- Stephen Ray Mitchell vs Tage Honore1 shared
Other insiders at the same companies
- Charles Cliff DuncanVNDA
- Daniel Patrick McGuireVNDA
- Phaedra ChrousosVNDA
- Richard W DuganVNDA
- Anne Sempowski WardVNDA
- Tage HonoreVNDA
- Polymeropoulos Christos Vasilios MihaelVNDA
- Scott Laverne HowellVNDA
- Timothy WilliamsVNDA
- Kevin Patrick MoranVNDA
- Joakim WijkstromVNDA
- Mihael Hristos PolymeropoulosVNDA
- Gunther BirznieksVNDA
Questions about Stephen Ray Mitchell
- What is Stephen Ray Mitchell's role at Vanda Pharmaceuticals Inc.?
- Stephen Ray Mitchell reports to the SEC as director at Vanda Pharmaceuticals Inc. (VNDA), according to the latest filing on June 8, 2026.
- How many shares does Stephen Ray Mitchell own?
- After the latest filing that states it, Stephen Ray Mitchell directly owned 112,846 shares of Vanda Pharmaceuticals Inc. (VNDA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Stephen Ray Mitchell bought or sold stock recently?
- The most recent open-market sale was on June 13, 2025: sold 7,000 shares of Vanda Pharmaceuticals Inc. (VNDA) for $32.1K at an average of $4.59.
- How do I get alerts when Stephen Ray Mitchell files?
- Follow Stephen Ray Mitchell on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Stephen Ray Mitchell (SEC CIK 0001802653). Totals count each trade once, skipping amendments whose original is on file, from Jun 14, 2021 on. View on SEC EDGAR